Phenylbutazone-based injectable solution. A nonsteroidal anti-inflammatory drug with analgesic, antipyretic, and anti-inflammatory effects. Indicated for acute and chronic inflammatory conditions. Arthritis, myositis, tendinitis, synovitis, hyperthermia.
FORMULA:
Each 100 ml contains
Phenylbutazone 20 g.
Excipients q.s.
DOSAGE:
Adults: On the first day, administer 5 to 10 ml, equivalent to 1 to 2 ml per 100 kg of body weight or 2.2 to 4.4 mg/kg.
Foals: On the first day, administer 1 to 2 ml for a foal weighing approximately 200 kg, equivalent to 1.1–2.2 mg/kg.
Starting on the second day, reduce the dose by half until the end of treatment.
CONTRAINDICATIONS:
Use with caution when administered concurrently with warfarin, aminoglycosides, penicillins, sulfonamides, furosemide, barbiturates, promazine, glucocorticoids, and other NSAIDs.
Do not use in pregnant or lactating females.
Do not use in animals with known hypersensitivity to phenylbutazone.
Do not administer to horses intended for human consumption.
Do not administer to patients with heart, kidney, or liver failure; gastroduodenal ulcer syndrome (SUGE); or to animals that are dehydrated, hypovolemic, hypotensive, or have hematological or bone marrow abnormalities.
At the indicated dose and duration of treatment, side effects are unlikely to occur.
In cases of hypersensitivity, gastrointestinal symptoms such as oral and gastrointestinal ulcers, diarrhea, and anorexia may occur.
INDICATED FOR:
Equines not intended for human consumption.
Do not administer to pregnant or lactating females.
DURATION OF TREATMENT:
The duration of treatment may be up to 7 days, adhering to the dose reduction and intervals between doses.
In acute cases, it may be administered every 12 hours on the first day and then every 24 hours. In subacute or chronic cases, administer every 24 hours.
The duration is at the discretion of the veterinarian.
In acute conditions, it may be administered every 12 hours on the first day and then every 24 hours. In subacute or chronic conditions, administer every 24 hours.
The duration of treatment is at the discretion of the treating professional based on the clinical presentation.
PRESENTATION:
Bottles of 100 ml and 250 ml.
Phenylbutazone-based injectable solution. A nonsteroidal anti-inflammatory drug with analgesic, antipyretic, and anti-inflammatory effects. Indicated for acute and chronic inflammatory conditions. Arthritis, myositis, tendinitis, synovitis, hyperthermia.
FORMULA:
Each 100 ml contains
Phenylbutazone 20 g.
Excipients q.s.
DOSAGE:
Adults: On the first day, administer 5 to 10 ml, equivalent to 1 to 2 ml per 100 kg of body weight or 2.2 to 4.4 mg/kg.
Foals: On the first day, administer 1 to 2 ml for a foal weighing approximately 200 kg, equivalent to 1.1–2.2 mg/kg.
Starting on the second day, reduce the dose by half until the end of treatment.
CONTRAINDICATIONS:
Use with caution when administered concurrently with warfarin, aminoglycosides, penicillins, sulfonamides, furosemide, barbiturates, promazine, glucocorticoids, and other NSAIDs.
Do not use in pregnant or lactating females.
Do not use in animals with known hypersensitivity to phenylbutazone.
Do not administer to horses intended for human consumption.
Do not administer to patients with heart, kidney, or liver failure; gastroduodenal ulcer syndrome (SUGE); or to animals that are dehydrated, hypovolemic, hypotensive, or have hematological or bone marrow abnormalities.
At the indicated dose and duration of treatment, side effects are unlikely to occur.
In cases of hypersensitivity, gastrointestinal symptoms such as oral and gastrointestinal ulcers, diarrhea, and anorexia may occur.
INDICATED FOR:
Equines not intended for human consumption.
Do not administer to pregnant or lactating females.
DURATION OF TREATMENT:
The duration of treatment may be up to 7 days, adhering to the dose reduction and intervals between doses.
In acute cases, it may be administered every 12 hours on the first day and then every 24 hours. In subacute or chronic cases, administer every 24 hours.
The duration is at the discretion of the veterinarian.
In acute conditions, it may be administered every 12 hours on the first day and then every 24 hours. In subacute or chronic conditions, administer every 24 hours.
The duration of treatment is at the discretion of the treating professional based on the clinical presentation.
PRESENTATION:
Bottles of 100 ml and 250 ml.
